Translational Research Initiative Will Use PanCancer IO 360 Panel to Identify Predictive Signatures for MGD013 SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that MacroGenics(NASDAQ:MGNX) and NanoString have entered into a translational research agreement to identify and develop biomarkers for MacroGenics’ MGD013 program. MGD013 is an IgG4κ bispecific […]
Sample to Insight solutions enabling deep analysis of disease-related genomic mutations Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of three innovative Sample to Insight workflows for next-generation sequencing (NGS) research in oncology using QIAGEN’s GeneReader NGS System and other NGS platforms. QIAGEN is introducing the […]
Most Powerful Sequencer to Date SHENZHEN, China — MGI, a subsidiary of BGI Group, introduced its newest model of genetic sequencer, MGISEQ-T7, which vastly improves speed, throughput and flexibility, at the 13th International Conference on Genomics (ICG-13) in Shenzhen. The most powerful MGI sequencer to date, MGISEQ-T7 is built with innovative quadruple flow-cell staging that allows simultaneous but independent […]
SAN FRANCISCO–Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the appointment of Ray Tabibiazar, M.D., as senior vice president of corporate development and business strategy as well as acting general manager of Twist Bioscience’s division focused on biologics drug discovery. “Ray has been working with […]
New premises at Milton Park, Oxfordshire, UK and in Boston, MA support rapid expansion of company Oxford, UK: Aigenpulse Ltd., (Aigenpulse), a company at the forefront of employing data technologies and advanced machine learning to accelerate drug discovery, today announced it has moved into larger premises at Milton Park, Oxfordshire, UK and opened offices […]
Vienna, Austria – RNA (ribonucleic acid) is one of the most important building blocks of life, and this molecule is researched in diverse biological disciplines. In 2016, the RNA Society launched the “RNA Salon” program to cultivate interactions between RNA researchers who might be regionally close but belong to various departments or institutes. This program provides […]
Congenica, the global diagnostic decision support platform provider, today announced a key partnership with the UK’s Epilepsy Society to study the genomics of sudden unexpected death in epilepsy (SUDEP). The new collaboration aims to improve the clinical understanding, prediction and treatment of the devastating and unpredictable condition, which affects approximately 1 in 1,000 adult and 1 in […]
Molecular Devices LLC, a leader in protein and cell biology technologies, today announced a new, exciting brand for its recently created biologics solutions business unit. The business unit combines the industry leading ForteBio label-free technology platform with Molecular Devices’ Biologics Biotherapeutics portfolio of products, and henceforth will be known as ForteBio. It is accompanied by […]
We’re excited to make two major announcements today. We have closed a $110M Series C investmentround led by Founders Fund and we have added Dr. Matthew Porteus, a pioneer in cell therapies, to our advisory board. Since the start of our journey at Synthego, we’ve been committed to making state-of-the-art genome engineering tools accessible to researchers […]
Innovative genomic and proteomic analysis platform for Immuno-Oncology and Immune Profiling Applications NATIONAL UNIVERSITY OF SINGAPORE Proteona Pte. Ltd. has entered into an exclusive worldwide licensing agreement with the National University of Singapore (NUS) for Enhanced Single Cell Analysis with Protein Expression (ESCAPETM) RNA sequencing technology, an innovative multifaceted single-cell sequencing platform for simultaneous protein […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
